IP Verse

Altor Bioscience competitive analysis

Loading summary...

Latest patents of Altor Bioscience opposed by its competitors

Explore Altor Bioscience's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3601363
Jun 15, 2022Alt-803 In Combination With Anti-Cd38 Antibody For Cancer Therapies1

Latest publications and patents of Altor Bioscience New

Explore the latest publications and patents granted to Altor Bioscience, showcasing their recent innovations and technological advancements.

Last updated on: Oct 22, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Altor Bioscience

EP3601363
Jun 15, 2022Alt-803 In Combination With Anti-Cd38 Antibody For Cancer TherapiesOpposition Rejected
EP2322228
Jan 10, 2018T Cell Receptor Fusions And Conjugates And Methods Of Use ThereofNo Opposition Filed Within Time Limit

Latest PTAB cases involving Altor Bioscience

Discover the latest PTAB cases involving Altor Bioscience, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Altor Bioscience with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ALTOR BIOSCIENCE - 1 - -
CYTUNE PHARMA27 - -